These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27582524)

  • 1. Macrophage Susceptibility to Emactuzumab (RG7155) Treatment.
    Pradel LP; Ooi CH; Romagnoli S; Cannarile MA; Sade H; Rüttinger D; Ries CH
    Mol Cancer Ther; 2016 Dec; 15(12):3077-3086. PubMed ID: 27582524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential contribution of tumor-associated slan
    Lonardi S; Licini S; Micheletti A; Finotti G; Vermi W; Cassatella MA
    J Leukoc Biol; 2018 Mar; 103(3):559-564. PubMed ID: 28951423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The c.1085A>G Genetic Variant of
    Yeh YM; Hsu SJ; Lin PC; Hsu KF; Wu PY; Su WC; Chang JY; Shen MR
    Clin Cancer Res; 2017 Oct; 23(20):6021-6030. PubMed ID: 28724665
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
    Ries CH; Cannarile MA; Hoves S; Benz J; Wartha K; Runza V; Rey-Giraud F; Pradel LP; Feuerhake F; Klaman I; Jones T; Jucknischke U; Scheiblich S; Kaluza K; Gorr IH; Walz A; Abiraj K; Cassier PA; Sica A; Gomez-Roca C; de Visser KE; Italiano A; Le Tourneau C; Delord JP; Levitsky H; Blay JY; Rüttinger D
    Cancer Cell; 2014 Jun; 25(6):846-59. PubMed ID: 24898549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of IL-10 and T
    Pradel LP; Franke A; Ries CH
    J Leukoc Biol; 2018 Mar; 103(3):545-558. PubMed ID: 29345363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.
    Haegel H; Thioudellet C; Hallet R; Geist M; Menguy T; Le Pogam F; Marchand JB; Toh ML; Duong V; Calcei A; Settelen N; Preville X; Hennequi M; Grellier B; Ancian P; Rissanen J; Clayette P; Guillen C; Rooke R; Bonnefoy JY
    MAbs; 2013; 5(5):736-47. PubMed ID: 23924795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.
    Polk A; Lu Y; Wang T; Seymour E; Bailey NG; Singer JW; Boonstra PS; Lim MS; Malek S; Wilcox RA
    Clin Cancer Res; 2016 Dec; 22(24):6118-6128. PubMed ID: 27334834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Ao JY; Zhu XD; Chai ZT; Cai H; Zhang YY; Zhang KZ; Kong LQ; Zhang N; Ye BG; Ma DN; Sun HC
    Mol Cancer Ther; 2017 Aug; 16(8):1544-1554. PubMed ID: 28572167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages.
    Gomez-Roca CA; Italiano A; Le Tourneau C; Cassier PA; Toulmonde M; D'Angelo SP; Campone M; Weber KL; Loirat D; Cannarile MA; Jegg AM; Ries C; Christen R; Meneses-Lorente G; Jacob W; Klaman I; Ooi CH; Watson C; Wonde K; Reis B; Michielin F; Rüttinger D; Delord JP; Blay JY
    Ann Oncol; 2019 Aug; 30(8):1381-1392. PubMed ID: 31114846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.
    Van Overmeire E; Stijlemans B; Heymann F; Keirsse J; Morias Y; Elkrim Y; Brys L; Abels C; Lahmar Q; Ergen C; Vereecke L; Tacke F; De Baetselier P; Van Ginderachter JA; Laoui D
    Cancer Res; 2016 Jan; 76(1):35-42. PubMed ID: 26573801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes.
    Webb MW; Sun J; Sheard MA; Liu WY; Wu HW; Jackson JR; Malvar J; Sposto R; Daniel D; Seeger RC
    Int J Cancer; 2018 Sep; 143(6):1483-1493. PubMed ID: 29665011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.
    Alexander KA; Flynn R; Lineburg KE; Kuns RD; Teal BE; Olver SD; Lor M; Raffelt NC; Koyama M; Leveque L; Le Texier L; Melino M; Markey KA; Varelias A; Engwerda C; Serody JS; Janela B; Ginhoux F; Clouston AD; Blazar BR; Hill GR; MacDonald KP
    J Clin Invest; 2014 Oct; 124(10):4266-80. PubMed ID: 25157821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro.
    Kitoh Y; Saio M; Gotoh N; Umemura N; Nonaka K; Bai J; Vizkeleti L; Torocsik D; Balazs M; Adany R; Takami T
    Int J Oncol; 2011 May; 38(5):1409-19. PubMed ID: 21373754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity.
    Wiehagen KR; Girgis NM; Yamada DH; Smith AA; Chan SR; Grewal IS; Quigley M; Verona RI
    Cancer Immunol Res; 2017 Dec; 5(12):1109-1121. PubMed ID: 29097420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2.
    Digiacomo G; Ziche M; Dello Sbarba P; Donnini S; Rovida E
    FASEB J; 2015 Jun; 29(6):2545-54. PubMed ID: 25757564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages.
    Bernasconi S; Matteucci C; Sironi M; Conni M; Colotta F; Mosca M; Colombo N; Bonazzi C; Landoni F; Corbetta G
    Int J Cancer; 1995 Jan; 60(3):300-7. PubMed ID: 7829234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colony-stimulating factor-1 receptor provides a growth advantage in epithelial cancer cell line A431 in the presence of epidermal growth factor receptor inhibitor gefitinib.
    Niehus SE; Tran DDH; Mischak M; Koch A
    Cell Signal; 2018 Nov; 51():191-198. PubMed ID: 30075184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.
    Peng X; Hou P; Chen Y; Dai Y; Ji Y; Shen Y; Su Y; Liu B; Wang Y; Sun D; Jiang Y; Zha C; Xie Z; Ding J; Geng M; Ai J
    J Exp Clin Cancer Res; 2019 Aug; 38(1):372. PubMed ID: 31438996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
    Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
    Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages.
    Ambarus CA; Krausz S; van Eijk M; Hamann J; Radstake TR; Reedquist KA; Tak PP; Baeten DL
    J Immunol Methods; 2012 Jan; 375(1-2):196-206. PubMed ID: 22075274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.